RAC 2.92% $1.94 race oncology ltd

Ann: MD Anderson Preclinical AML Study on Zantrene Published, page-49

  1. 510 Posts.
    lightbulb Created with Sketch. 183
    Whats the point of investing in a high risk company if you are going to wait until the results of a clinical trial are released ?

    We are all aware of the high risk nature of our investment as we acknowledge that risk by investing in Race before the trial results are out.

    By your logic, we should just invest in an index fund.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.